Author
Silvius Alexandru Pescariu
Recent research
- Health & MedicineOpen access
Background: Fosmanogepix is a first-in-class Gwt1 inhibitor with oral and intravenous formulations and broad in vitro activity, but its clinical evidence is scattered across small trials and case reports. We reviewed all identifiable human data from the searched sources on its ef...